![Andrew Bolt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Bolt is the founder of SphynKx Therapeutics LLC, which he founded in 2010 and where he currently holds the titles of President & Chief Executive Officer.
Mr. Bolt's former jobs include being a Principal at Millennium Pharmaceuticals, Inc. and Deloitte Consulting LLP, as well as a Cancer Biologist at Millennium Predictive Medicine, Inc. Mr. Bolt's education includes an undergraduate and graduate degree from the University of Connecticut and an MBA from the University of Virginia Darden School of Business.
| Companies | Position | End |
|---|---|---|
Deloitte Consulting LLP
 Deloitte Consulting LLP Miscellaneous Commercial ServicesCommercial Services Provides financial consulting services | Corporate Officer/Principal | - |
Millennium Predictive Medicine, Inc. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
SphynKx Therapeutics LLC
 SphynKx Therapeutics LLC Pharmaceuticals: MajorHealth Technology Engages in developing, discovering and commercializing novel therapies for the treatment of fibrosis | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Deloitte Consulting LLP
Deloitte Consulting LLP Miscellaneous Commercial ServicesCommercial Services Provides financial consulting services | Commercial Services |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millennium Predictive Medicine, Inc. | |
SphynKx Therapeutics LLC
SphynKx Therapeutics LLC Pharmaceuticals: MajorHealth Technology Engages in developing, discovering and commercializing novel therapies for the treatment of fibrosis | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
